Sfoglia per Autore
Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy
2018-01-01 Allen, W. L.; Dunne, P. D.; Mcdade, S.; Scanlon, E.; Loughrey, M.; Coleman, H. G.; Mccann, C.; Mclaughlin, K.; Nemeth, Z.; Syed, N. A.; Jithesh, P. V.; Arthur, K.; Wilson, R.; Coyle, V. M.; Mcart, D.; Murray, G. I.; Samuel, L.; Nuciforo, P.; Jimenez, J.; Argiles, G.; Dienstmann, R.; Tabernero, J.; Picariello, L.; Messerini, L.; Nobili, S.; Mini, E.; Sheahan, K.; Ryan, E.; Johnston, P. G.; Van Schaeybroeck, S.; Lawler, M.; Longley, D. B.
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer
2019-01-01 Marzo, T.; Massai, L.; Pratesi, A.; Stefanini, M.; Cirri, D.; Magherini, F.; Becatti, M.; Landini, I.; Nobili, S.; Mini, E.; Crociani, O.; Arcangeli, A.; Pillozzi, S.; Gamberi, T.; Messori, L.
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer
2019-01-01 Roviello, G.; Conter, F. U.; Mini, E.; Generali, D.; Traversini, M.; Lavacchi, D.; Nobili, S.; Sobhani, N.
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy
2019-01-01 Mini, E.; Lapucci, A.; Perrone, G.; D'Aurizio, R.; Napoli, C.; Brugia, M.; Landini, I.; Tassi, R.; Picariello, L.; Simi, L.; Mancini, I.; Messerini, L.; Magi, A.; Pinzani, P.; Mazzei, T.; Tonelli, F.; Nobili, S.
A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development
2019-01-01 Roviello, G.; Nobili, S.; Mini, E.
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
2020-01-01 Roviello, G.; D'Angelo, A.; Petrioli, R.; Roviello, F.; Cianchi, F.; Nobili, S.; Mini, E.; Lavacchi, D.
An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC)
2020-01-01 D'Angelo, A.; Bagby, S.; Di Pierro, G.; Chirra, M.; Nobili, S.; Mini, E.; Villari, D.; Roviello, G.
TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directions
2020-01-01 Roviello, G.; D'Angelo, A.; Sciortino, M.; Mini, E.; Nobili, S.; De Logu, F.; Massi, D.
Immune checkpoint inhibitors in pre-treated gastric cancer patients: Results from a literature-based meta-analysis
2020-01-01 Roviello, G.; Corona, S. P.; D'Angelo, A.; Rosellini, P.; Nobili, S.; Mini, E.
Clinical outcomes and safety of patients treated with NAb-Paclitaxel plus Gemcitabine in metastatic pancreatic cancer: the NAPA study
2020-01-01 Catalano, Martina; Roviello, Giandomenico; Conca, Raffaele; D'Angelo, Alberto; Palmieri, Valeria Emma; Panella, Benedetta; Petrioli, Roberto; Ianza, Anna; Nobili, Stefania; Mini, Enrico; Ramello, Monica
Role of ATP-binding cassette transporters in cancer initiation and progression
2020-01-01 Nobili, S.; Lapucci, A.; Landini, I.; Coronnello, M.; Roviello, G.; Mini, E.
TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination
2020-01-01 Roviello, G.; Fancelli, S.; Gatta Michelet, M. R.; Aprile, G.; Nobili, S.; Roviello, F.; Cianchi, F.; Mini, E.; Lavacchi, D.
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment
2020-01-01 Roviello, G.; Casadei-Gardini, A.; Nobili, S.; Mini, E.; Fancelli, S.
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer
2020-01-01 Roviello, G.; Ramello, M.; Catalano, M.; D'Angelo, A.; Conca, R.; Gasperoni, S.; Dreoni, L.; Petrioli, R.; Ianza, A.; Nobili, S.; Aieta, M.; Mini, E.
Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trials
2020-01-01 Roviello, G.; Gatta Michelet, M. R.; D'Angelo, A.; Nobili, S.; Mini, E.
Focus on biochemical and clinical predictors of response to immune checkpoint inhibitors in metastatic urothelial carcinoma: Where do we stand?
2020-01-01 Roviello, G.; Catalano, M.; Nobili, S.; Santi, R.; Mini, E.; Nesi, G.
Vinorelbine in non-small cell lung cancer: Real-world data from a single-institution experience
2020-01-01 Nobili, S.; Lavacchi, D.; Perrone, G.; Vicini, G.; Tassi, R.; Landini, I.; Grosso, A.; Roviello, G.; Mazzanti, R.; Santomaggio, C.; Mini, E.
Some suggestions from pk/pd principles to contain resistance in the clinical setting—focus on icu patients and gram-negative strains
2020-01-01 Adembri, C.; Novelli, A.; Nobili, S.
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties
2020-01-01 Landini, I.; Massai, L.; Cirri, D.; Gamberi, T.; Paoli, P.; Messori, L.; Mini, E.; Nobili, S.
Maintenance in gastric cancer: New life for an old issue?
2021-01-01 Roviello, G.; Rodriquenz, M. G.; Aprile, G.; D'Angelo, A.; Roviello, F.; Nobili, S.; Mini, E.; Sarno, I.; Polom, K.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy | 2018 | Allen, W. L.; Dunne, P. D.; Mcdade, S.; Scanlon, E.; Loughrey, M.; Coleman, H. G.; Mccann, C.; Mclaughlin, K.; Nemeth, Z.; Syed, N. A.; Jithesh, P. V.; Arthur, K.; Wilson, R.; Coyle, V. M.; Mcart, D.; Murray, G. I.; Samuel, L.; Nuciforo, P.; Jimenez, J.; Argiles, G.; Dienstmann, R.; Tabernero, J.; Picariello, L.; Messerini, L.; Nobili, S.; Mini, E.; Sheahan, K.; Ryan, E.; Johnston, P. G.; Van Schaeybroeck, S.; Lawler, M.; Longley, D. B. | |
| Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer | 2019 | Marzo, T.; Massai, L.; Pratesi, A.; Stefanini, M.; Cirri, D.; Magherini, F.; Becatti, M.; Landini, I.; Nobili, S.; Mini, E.; Crociani, O.; Arcangeli, A.; Pillozzi, S.; Gamberi, T.; Messori, L. | |
| Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer | 2019 | Roviello, G.; Conter, F. U.; Mini, E.; Generali, D.; Traversini, M.; Lavacchi, D.; Nobili, S.; Sobhani, N. | |
| RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy | 2019 | Mini, E.; Lapucci, A.; Perrone, G.; D'Aurizio, R.; Napoli, C.; Brugia, M.; Landini, I.; Tassi, R.; Picariello, L.; Simi, L.; Mancini, I.; Messerini, L.; Magi, A.; Pinzani, P.; Mazzei, T.; Tonelli, F.; Nobili, S. | |
| A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development | 2019 | Roviello, G.; Nobili, S.; Mini, E. | |
| Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer | 2020 | Roviello, G.; D'Angelo, A.; Petrioli, R.; Roviello, F.; Cianchi, F.; Nobili, S.; Mini, E.; Lavacchi, D. | |
| An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC) | 2020 | D'Angelo, A.; Bagby, S.; Di Pierro, G.; Chirra, M.; Nobili, S.; Mini, E.; Villari, D.; Roviello, G. | |
| TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directions | 2020 | Roviello, G.; D'Angelo, A.; Sciortino, M.; Mini, E.; Nobili, S.; De Logu, F.; Massi, D. | |
| Immune checkpoint inhibitors in pre-treated gastric cancer patients: Results from a literature-based meta-analysis | 2020 | Roviello, G.; Corona, S. P.; D'Angelo, A.; Rosellini, P.; Nobili, S.; Mini, E. | |
| Clinical outcomes and safety of patients treated with NAb-Paclitaxel plus Gemcitabine in metastatic pancreatic cancer: the NAPA study | 2020 | Catalano, Martina; Roviello, Giandomenico; Conca, Raffaele; D'Angelo, Alberto; Palmieri, Valeria Emma; Panella, Benedetta; Petrioli, Roberto; Ianza, Anna; Nobili, Stefania; Mini, Enrico; Ramello, Monica | |
| Role of ATP-binding cassette transporters in cancer initiation and progression | 2020 | Nobili, S.; Lapucci, A.; Landini, I.; Coronnello, M.; Roviello, G.; Mini, E. | |
| TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination | 2020 | Roviello, G.; Fancelli, S.; Gatta Michelet, M. R.; Aprile, G.; Nobili, S.; Roviello, F.; Cianchi, F.; Mini, E.; Lavacchi, D. | |
| Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment | 2020 | Roviello, G.; Casadei-Gardini, A.; Nobili, S.; Mini, E.; Fancelli, S. | |
| Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer | 2020 | Roviello, G.; Ramello, M.; Catalano, M.; D'Angelo, A.; Conca, R.; Gasperoni, S.; Dreoni, L.; Petrioli, R.; Ianza, A.; Nobili, S.; Aieta, M.; Mini, E. | |
| Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trials | 2020 | Roviello, G.; Gatta Michelet, M. R.; D'Angelo, A.; Nobili, S.; Mini, E. | |
| Focus on biochemical and clinical predictors of response to immune checkpoint inhibitors in metastatic urothelial carcinoma: Where do we stand? | 2020 | Roviello, G.; Catalano, M.; Nobili, S.; Santi, R.; Mini, E.; Nesi, G. | |
| Vinorelbine in non-small cell lung cancer: Real-world data from a single-institution experience | 2020 | Nobili, S.; Lavacchi, D.; Perrone, G.; Vicini, G.; Tassi, R.; Landini, I.; Grosso, A.; Roviello, G.; Mazzanti, R.; Santomaggio, C.; Mini, E. | |
| Some suggestions from pk/pd principles to contain resistance in the clinical setting—focus on icu patients and gram-negative strains | 2020 | Adembri, C.; Novelli, A.; Nobili, S. | |
| Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties | 2020 | Landini, I.; Massai, L.; Cirri, D.; Gamberi, T.; Paoli, P.; Messori, L.; Mini, E.; Nobili, S. | |
| Maintenance in gastric cancer: New life for an old issue? | 2021 | Roviello, G.; Rodriquenz, M. G.; Aprile, G.; D'Angelo, A.; Roviello, F.; Nobili, S.; Mini, E.; Sarno, I.; Polom, K. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile